FOLH1 and lymph node disorder: A follow-up 68Ga-PSMA-11 PET/CT scan (Figure 4B) after five months showed progressive lymph node disease and increased 68Ga-PSMA-11 uptake sufficient for 177Lu-PSMA-617 RLT.